Dual intracellular targeting by ruxolitinib and Mcl-1 inhibitor S63845 in IL-6 dependent myeloma cells blocks in vivo tumor growth.

Like Comment
Not available.

View the full article @ Haematologica

Get PDF with LibKey
Authors: Renate Burger, Anna Otte, Jan Brdon, Matthias Peipp, Martin Gramatzki


The wider, wiser view for healthcare professionals. ClinOwl signposts the latest clinical content from over 100 leading medical journals.
6577 Contributions
0 Following